CSL CEO Paul Perreault Focuses on Patient-Centric Leadership in Pharma
Go back to CSL CEO Paul Perreault Focuses on Patient-Centric Leadership in Pharma| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 319.82 -0.54 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $320.36 | 52 Week High | $114.49 | |||
| Open | $323.60 | 52 Week Low | $75.17 | |||
| Day High | $323.60 | P/E | 88.59 | |||
| Day Low | $317.47 | EPS | $3.61 | |||
| Volume | 228,770 | |||||
| (AMEX: CSLLY) | Delayed: 32.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.21 | 52 Week High | $45.60 | |||
| Open | $32.07 | 52 Week Low | $33.39 | |||
| Day High | $32.84 | P/E | N/A | |||
| Day Low | $32.07 | EPS | $0.00 | |||
| Volume | 43,115 | |||||



